# Retrospective Survey Evaluating the Effectiveness and Safety of Dual Inhibition Lipid-lowering in the Treatment of Dyslipidemia (Study P05171)(COMPLETED)

> **NCT00726856** · — · COMPLETED · sponsor: **Organon and Co** · enrollment: 1200 (estimated)

## Conditions studied

- Dyslipidemia

## Interventions

- **DRUG:** Ezetimibe 10 mg plus statin or ezetimibe 10 mg plus fenofibrate

## Key facts

- **NCT ID:** NCT00726856
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2007-07
- **Final completion:** 2007-07
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2022-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00726856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00726856, "Retrospective Survey Evaluating the Effectiveness and Safety of Dual Inhibition Lipid-lowering in the Treatment of Dyslipidemia (Study P05171)(COMPLETED)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00726856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*